Good Health Can’t Wait.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Consolidated Financial Statements<br />
Annual Report 2014 - 15<br />
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS<br />
(All amounts in Indian Rupees millions, except share data and where otherwise stated)<br />
m) Derivative instruments and hedge accounting<br />
The Company uses forward contracts, option contracts and swap contracts (derivatives) to mitigate its risk of changes in foreign currency exchange<br />
rates and interest rates. The Company does not use derivatives for trading or speculative purposes.<br />
The premium or discount on foreign exchange forward contracts is amortized as income or expense over the life of the contract. The exchange<br />
difference is calculated and recorded in accordance with AS11 (revised), “The Effect of Changes in Foreign Exchange Rates” in the statement of profit<br />
and loss. The changes in the fair value of foreign currency option contracts and swap contracts are recognised in the statement of profit and loss as<br />
they arise. Fair value of such option contracts and swap contracts is determined based on the appropriate valuation techniques considering the terms<br />
of the contract.<br />
Pursuant to the ICAI Announcement “Accounting for Derivatives” on the early adoption of AS 30 “Financial Instruments: Recognition and Measurement”,<br />
the Company has adopted the Standard, to the extent that the adoption does not conflict with existing mandatory accounting standards and other<br />
authoritative pronouncements, the Companies Act, 2013 and other regulatory requirements.<br />
Cash flow hedges<br />
The Company classifies its derivative contracts that hedge foreign currency risk associated with highly probable forecasted transactions as cash<br />
flow hedges and measures them at fair value. The effective portion of such cash flow hedges is recorded as part of reserves and surplus within the<br />
Company’s “hedging reserve”, and re-classified into the statement of profit and loss as revenue in the period corresponding to the occurrence of the<br />
forecasted transactions. The ineffective portion is immediately recorded in the statement of profit and loss.<br />
The Company also designates certain non-derivative financial liabilities, such as foreign currency borrowings from banks, as hedging instruments<br />
for the hedge of foreign currency risk associated with highly probable forecasted transactions and, accordingly, applies cash flow hedge accounting<br />
for such relationships. Re-measurement gain/loss on such non-derivative financial liabilities is recorded as part of reserves and surplus within the<br />
Company’s “hedging reserve”, and re-classified in the statement of profit and loss as revenue in the period corresponding to the occurrence of the<br />
forecasted transactions.<br />
If the hedging instrument no longer meets the criteria for hedge accounting, gets expired or is sold, terminated or exercised before the occurrence of<br />
the forecasted transaction, the hedge accounting on such transaction is discontinued prospectively. The cumulative gain or loss previously recognized<br />
in hedging reserve continues to remain there until the forecasted transaction occurs. If the forecasted transaction is no longer expected to occur, the<br />
balance in hedging reserve is recognized immediately in the statement of profit and loss.<br />
n) Revenue recognition<br />
Sale of goods<br />
Revenue is recognized when the significant risks and rewards of ownership have been transferred to the buyer, recovery of the consideration is<br />
reasonably certain, the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with<br />
the goods and the amount of revenue can be measured reliably.<br />
Revenue from the sale of goods includes excise duty and is net of returns, sales tax and applicable trade discounts and allowances.<br />
Revenue includes shipping and handling costs billed to the customer.<br />
Provision for chargeback, rebates and discounts<br />
Accrual for chargeback, rebates, discounts and medicaid payments are estimated and provided for in the year of sales and recorded as reduction of<br />
revenue. A chargeback claim is a claim made by the wholesaler for the difference between the price at which the product is initially invoiced to the<br />
wholesaler and the net price at which it is agreed to be procured from the Company. Accrual for such chargeback is made considering the factors such<br />
as historical average chargeback rate actually claimed over a period of time, current contract prices with wholesalers / other customers and estimated<br />
inventory holding by the wholesaler.<br />
Sales returns<br />
The Company accounts for sales returns by recording an allowance for sales returns concurrent with the recognition of revenue at the time of a<br />
product sale. This allowance is based on the Company’s estimate of expected sales returns. The estimate of sales returns is determined primarily by<br />
the Company’s historical experience in the markets in which the Company operates.<br />
Profit share revenues<br />
From time to time the Company enters into various marketing arrangements with its business partners for the sale of its products. Under such<br />
arrangements, the Company sells its products to the business partners at a price agreed upon in the arrangement and is also entitled to a profit<br />
share which is over and above the agreed price. Revenue in an amount equal to the agreed price is recognized on these transactions upon delivery<br />
of products to the business partners. The additional amount representing the profit share component is recognized as revenue in the period which<br />
corresponds to the ultimate sales made by business partners only when the collectability of the profit share becomes probable and a reliable measure<br />
of the profit share is available.<br />
177